Skip to main content

Together we are beating cancer

Donate now

Ovarian cancer

Ovarian cancer is the 6th most common cancer in women in the UK, with 7,400 people diagnosed each year. The symptoms of ovarian cancer can be very vague, particularly when the disease is in its early stages.
Showing 12 out of 158 results

In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs. In the latest in Our Milestones series, we look at how Cancer Research UK scientists helped develop one of the world’s most successful cancer drugs.

by Lucy Holmes | Analysis | 26 August 2015

26 August 2015

This entry is part 23 of 30 in the series Our milestones
%postcontent%
RAD51 cartoon

Our researchers have solved a decades-old genetic mystery about how DNA damage is repaired, thanks to some tiny worms. Our researchers have solved a decades-old genetic mystery about how DNA damage is repaired, thanks to some tiny worms.

by Kat Arney | Analysis | 20 July 2015

20 July 2015

Francis Crick Institute scientists have solved a decades-old mystery and helped to unravel the genetic cause of some breast and ovarian cancers Francis Crick Institute scientists have solved a decades-old mystery and helped to unravel the genetic cause of some breast and ovarian cancers

by Cancer Research UK | News | 16 July 2015

16 July 2015

Drugs

In light of a preliminary 'no' from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug's development In light of a preliminary 'no' from NICE over olaparib for ovarian cancer, we hear from one of our experts whose work led to the drug's development

by Cancer Research UK | Analysis | 1 June 2015

1 June 2015

Patchwork quilt
  • Science & Technology
  • Health & Medicine

Unpicking the genetic ‘patchwork’ in ovarian cancer

Our researchers are investigating the genetic 'patchwork' underlying ovarian tumours, which will lead to more effective treatments in the future. Our researchers are investigating the genetic 'patchwork' underlying ovarian tumours, which will lead to more effective treatments in the future.

by Kat Arney | Analysis | 12 March 2015

12 March 2015

Paper DNA

A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes. A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes.

by Kat Arney | Analysis | 24 February 2015

24 February 2015

The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells. The most common type of ovarian cancer is more deadly if it consists of a patchwork of different groups of cells.

by Cancer Research UK | News | 24 February 2015

24 February 2015